Inspire Medical Systems (STU:2DR) Research & Development: €87.0 Mil (TTM As of Mar. 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
55 GF Score
Price €38.40
GF Value €192.49
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Research & Development?

Inspire Medical Systems STU:2DR +1.59% 55 Research & Development is €87.0 Mil as of Mar. 2026. GuruFocus rates STU:2DR with a GF Score™ of 55/100 and a GF Value™ of €192.49 (Possible Value Trap). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Inspire Medical Systems's Research & Development for the three months ended in Mar. 2026 was €22.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €87.0 Mil.

Inspire Medical Systems  (STU:2DR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Inspire Medical Systems Research & Development Related Terms

Inspire Medical Systems Research & Development Historical Data

* Premium members only.

The historical data trend for Inspire Medical Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems Research & Development Chart

Inspire Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.06 64.80 106.86 108.99 88.10

Inspire Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.72 22.72 20.63 21.30 22.34
STU:2DR
55GF Score
Inspire Medical Systems Inc STU:2DR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €87.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €87.0 Mil mean?
Inspire Medical Systems (STU:2DR) has a Research & Development of €87.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Inspire Medical Systems and its competitors.
Is Inspire Medical Systems' Research & Development too high?
Inspire Medical Systems' current Research & Development is €87.0 Mil. Overall, Inspire Medical Systems has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Research & Development compare to BFLY and ATEC?
Inspire Medical Systems' Research & Development of €87.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Inspire Medical Systems and its competitors. Inspire Medical Systems's current Research & Development is €87.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €192.49, compared to a current price of €38.40 — trading 80.1% below its estimated fair value. The current Research & Development is €87.0 Mil. Inspire Medical Systems' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Research & Development is €87.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €38.40 is trading 80.1% below its estimated GF Value™ of €192.49. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Research & Development: €87.0 Mil
  • GF Value™: €192.49 vs. price of €38.40 (80.1% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
55GF Score

Get the complete analysis for STU:2DR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.40
Price
€192.49
GF Value